Assessment of latent tuberculosis infection in Takayasu arteritis with tuberculin skin test and Quantiferon-TB Gold test
- 376 Downloads
A possible relationship between Takayasu arteritis (TA) and tuberculosis (TB) has been suggested. An increased frequency of tuberculin skin test (TST) was observed in TA patients. Quantiferon-TB Gold test (QFT) is a new in vitro assay measuring interferon-gamma response to M. tuberculosis antigens and helpful in diagnosing latent TB infection. The aim of this study was to investigate latent TB infection among TA patients by the use of both TST and QFT Gold test. Ninety-four (male/female: 7/87) TA patients fulfilling ACR 1990 TA criteria from three different university hospitals in Turkey and 107 control subjects without inflammatory diseases were included in the study. Data about medical history (TA and TB) were collected for both groups. TST and QFT were performed. TST values ≥5 mm for TA patients and ≥15 mm for controls was accepted as TST positivity. Even though TA group was older (40 ± 12 vs. 32 ± 8, P < 0.001), there was no significant difference between TA patients and controls regarding demographic characteristics. Six TA patients and one control had a history of previous TB infection (P = 0.054). Although TST positivity was higher in TA group [55 patients (62.5%) vs. 24 controls (41.4%), P = 0.008], QFT positivity was similar between two groups [21 patients (22.3%) vs. 24 controls (22.4%), P > 0.05]. QFT was negative in two of six TA patients with previous TB history. Rate of latent TB infection in TA patients measured with QFT is no more than controls. QFT seems to be a good and favorable test compared with TST in detecting LTBI in TA.
KeywordsTuberculosis Takayasu arteritis Tuberculin skin test Quantiferon-TB Gold test
We thank MicroELISA Unit of Clinical Pathology Laboratory Staff of Hacettepe University Hospitals for the laboratory support.
Conflict of interest statement
- 9.Quantiferon-TB Gold IT at http://www.ellestis.com
- 10.Özkara Ş, Aktaş Z, Özkan S, Ecevit H (2003) The book for controlling tuberculosis in Turkey. p 55Google Scholar
- 11.Moraes MF, Ordway D, Oliveira L, Costa IL, Badura R, Pinheiro MN, de Graça JM, Ventura FA (1999) Cellular immune responses to Mycobacterium tuberculosis in a patient with Takayasu’s arteritis. Rev Port Cadiol 18(4):359–367Google Scholar
- 13.Kalyoncu U, Cobanoglu N, Akdogan A, Karadag O, Kisacik B, Maras Y, Bilgen SA, Calguneri M, Ozcelik U, Kiraz S, Ertenli I (2007) Using an interferon gamma assay for the diagnosis of tuberculosis infection before using tumor necrosis factor alpha blockers. Ann Rheum Dis 66(Suppl II):175Google Scholar
- 14.Ates A, Tabuk O, Ozturk N, Aksaray S (2008) Detection of latent tuberculosis in immunosuppressed patients with rheumatic diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon-gamma assay. Ann Rheum Dis 67(Suppl II):417Google Scholar
- 17.Bartalesi F, Vicidomini S, Goletti D, Fiorelli C, Fiori G, Melchiorre D, Tortoli E, Mantella A, Benucci M, Girardi E, Cerinic MM, Bartoloni A (2009) QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases. Eur Respir J 33(3):586–593CrossRefPubMedGoogle Scholar
- 21.Global tuberculosis control—epidemiology, strategy, financing WHO Report 2009. WHO/HTM/TB/2009.411Google Scholar
- 23.Hoffman GS, Merkel PA, Brasington RD, Lenschow DJ, Liang P (2004) Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Ann Rheum Dis 50(7):2296–2304Google Scholar